A PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CAPLACIZUMAB WITHOUT FIRST-LINE THERAPEUTIC PLASMA EXCHANGE IN ADULTS WITH IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA Sriya GUNAWARDENA; Angela HU; Laurel A. MENAPACE; Hikaru OKADA; Beverly ACCOMANDO; Julie LIN;